細胞・遺伝子治療CDMOサービスの世界市場に関する洞察、2030年までの予測

当レポートは、細胞・遺伝子治療CDMOサービス (Cell and Gene Therapy CDMO Services) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

• 調査範囲
• 市場分析：タイプ別
  • 世界の細胞・遺伝子治療CDMOサービスの市場規模成長率：タイプ別: 2019 VS 2023 VS 2030
  • Autologous Cell Therapy Products
  • Allogeneic Cell Therapy Products
• 市場：用途別
  • 世界の細胞・遺伝子治療CDMOサービスの市場シェア：用途別: 2019 VS 2023 VS 2030
  • SMBs
  • Large Companies
• 前提条件と制限
• 調査目的
• 対象期間

第2章 世界の市場成長トレンド

• 世界の細胞・遺伝子治療CDMOサービスの市場展望 (2019-2030)
• 世界の細胞・遺伝子治療CDMOサービスの市場成長トレンド：地域別
  • 世界の細胞・遺伝子治療CDMOサービス 市場規模：地域別: 2019 VS 2023 VS 2030
  • 細胞・遺伝子治療CDMOサービスの市場規模実績：地域別 (2019-2024)
  • 細胞・遺伝子治療CDMOサービスの市場規模予測：地域別 (2025-2030)
• 細胞・遺伝子治療CDMOサービス 市場動向
  • 細胞・遺伝子治療CDMOサービス 業界動向
  • 細胞・遺伝子治療CDMOサービス 市場の促進要因
  • 細胞・遺伝子治療CDMOサービス 市場の課題
  • 細胞・遺伝子治療CDMOサービス 市場の抑制要因

第3章 競合情勢：主要企業別

• 世界規模の売上高 細胞・遺伝子治療CDMOサービス ：競合別
  • 世界の細胞・遺伝子治療CDMOサービスの収益：企業別 (2019-2024)
  • 世界の細胞・遺伝子治療CDMOサービスの収益シェア：企業別 (2019-2024)
• 世界の細胞・遺伝子治療CDMOサービスの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
• 世界の主要企業 細胞・遺伝子治療CDMOサービス, 売上高ランキング, 2022 VS 2023 VS 2024
• 世界の細胞・遺伝子治療CDMOサービス 市場集中度
  • 世界の細胞・遺伝子治療CDMOサービス 市場集中度 (CR5 and HHI)
  • 世界の上位10・上位5企業： 細胞・遺伝子治療CDMOサービスの収益 2023
• 世界の主要企業 細胞・遺伝子治療CDMOサービス 本社 および提供地域
• 世界の主要企業 細胞・遺伝子治療CDMOサービス, 製品およびアプリケーション
• 世界の主要企業 細胞・遺伝子治療CDMOサービス, 業界参入時期
• M&A, 拡張計画

第4章 細胞・遺伝子治療CDMOサービス 内訳データ：タイプ別

• 世界の細胞・遺伝子治療CDMOサービスの市場規模実績：タイプ別 (2019-2024)
• 世界の細胞・遺伝子治療CDMOサービスの市場規模予測：タイプ別 (2025-2030)

第5章 細胞・遺伝子治療CDMOサービス 内訳データ：用途別

• 世界の細胞・遺伝子治療CDMOサービスの市場規模実績：用途別 (2019-2024)
• 世界の細胞・遺伝子治療CDMOサービスの市場規模予測：用途別 (2025-2030)

第6章 北米

• 北米の細胞・遺伝子治療CDMOサービス 市場規模 (2019-2030)
• 北米の細胞・遺伝子治療CDMOサービス 市場規模：タイプ別
  • 北米の細胞・遺伝子治療CDMOサービス 市場規模：タイプ別 (2019-2024)
  • 北米の細胞・遺伝子治療CDMOサービス 市場規模：タイプ別 (2025-2030)
  • 北米の細胞・遺伝子治療CDMOサービスの市場シェア：タイプ別 (2019-2030)
• 北米の細胞・遺伝子治療CDMOサービス 市場規模：用途別
  • 北米の細胞・遺伝子治療CDMOサービス 市場規模：用途別 (2019-2024)
  • 北米の細胞・遺伝子治療CDMOサービス 市場規模：用途別 (2025-2030)
  • 北米の細胞・遺伝子治療CDMOサービスの市場シェア：用途別 (2019-2030)
• 北米の細胞・遺伝子治療CDMOサービス 市場規模：国別
  • 北米の細胞・遺伝子治療CDMOサービス 市場規模：国別: 2019 VS 2023 VS 2030
  • 北米の細胞・遺伝子治療CDMOサービス 市場規模：国別 (2019-2024)
  • 北米の細胞・遺伝子治療CDMOサービス 市場 シェア 国別 (2025-2030)
  • 米国
  • カナダ

第7章 欧州

• 欧州の細胞・遺伝子治療CDMOサービス 市場規模 (2019-2030)
• 欧州の細胞・遺伝子治療CDMOサービス 市場規模：タイプ別
  • 欧州の細胞・遺伝子治療CDMOサービス 市場規模：タイプ別 (2019-2024)
  • 欧州の細胞・遺伝子治療CDMOサービス 市場規模：タイプ別 (2025-2030)
  • 欧州の細胞・遺伝子治療CDMOサービスの市場シェア：タイプ別 (2019-2030)
• 欧州の細胞・遺伝子治療CDMOサービス 市場規模：用途別
  • 欧州の細胞・遺伝子治療CDMOサービス 市場規模：用途別 (2019-2024)
  • 欧州の細胞・遺伝子治療CDMOサービス 市場規模：用途別 (2025-2030)
  • 欧州の細胞・遺伝子治療CDMOサービスの市場シェア：用途別 (2019-2030)
• 欧州の細胞・遺伝子治療CDMOサービス 市場規模：国別
  • 欧州の細胞・遺伝子治療CDMOサービス 市場規模：国別: 2019 VS 2023 VS 2030
  • 欧州の細胞・遺伝子治療CDMOサービス 市場規模：国別 (2019-2024)
  • 欧州の細胞・遺伝子治療CDMOサービス 市場規模：国別 (2025-2030)
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • ロシア
  • 北欧

第8章 中国

• 中国の細胞・遺伝子治療CDMOサービス 市場規模 (2019-2030)
• 中国の細胞・遺伝子治療CDMOサービス 市場規模：タイプ別
  • 中国の細胞・遺伝子治療CDMOサービス 市場規模：タイプ別 (2019-2024)
  • 中国の細胞・遺伝子治療CDMOサービス 市場規模：タイプ別 (2025-2030)
  • 中国の細胞・遺伝子治療CDMOサービスの市場シェア：タイプ別 (2019-2030)
• 中国の細胞・遺伝子治療CDMOサービス 市場規模：用途別
  • 中国の細胞・遺伝子治療CDMOサービス 市場規模：用途別 (2019-2024)
  • 中国の細胞・遺伝子治療CDMOサービス 市場規模：用途別 (2025-2030)
  • 中国の細胞・遺伝子治療CDMOサービスの市場シェア：用途別 (2019-2030)

第9章 アジア（中国を除く）

• アジア地域 細胞・遺伝子治療CDMOサービス 市場規模 (2019-2030)
• アジア地域 細胞・遺伝子治療CDMOサービス 市場規模：タイプ別
  • アジア地域 細胞・遺伝子治療CDMOサービス 市場規模：タイプ別 (2019-2024)
  • アジア地域 細胞・遺伝子治療CDMOサービス 市場規模：タイプ別 (2025-2030)
  • アジア地域 細胞・遺伝子治療CDMOサービスの市場シェア：タイプ別 (2019-2030)
• アジア地域 細胞・遺伝子治療CDMOサービス 市場規模：用途別
  • アジア地域 細胞・遺伝子治療CDMOサービス 市場規模：用途別 (2019-2024)
  • アジア地域 細胞・遺伝子治療CDMOサービス 市場規模：用途別 (2025-2030)
  • アジア地域 細胞・遺伝子治療CDMOサービスの市場シェア：用途別 (2019-2030)
• アジア地域 細胞・遺伝子治療CDMOサービス 市場規模：地域別
  • アジア地域 細胞・遺伝子治療CDMOサービス 市場規模：地域別: 2019 VS 2023 VS 2030
  • アジア地域 細胞・遺伝子治療CDMOサービス 市場規模：地域別 (2019-2024)
  • アジア地域 細胞・遺伝子治療CDMOサービス 市場規模：地域別 (2025-2030)
  • 日本
  • 韓国
  • 台湾
  • 東南アジア
  • インド
  • オーストラリア

第10章 中近東・アフリカ・中南米

• 中近東・アフリカ・中南米 細胞・遺伝子治療CDMOサービス 市場規模 (2019-2030)
• 中近東・アフリカ・中南米 細胞・遺伝子治療CDMOサービス 市場規模：タイプ別
  • 中近東・アフリカ・中南米 細胞・遺伝子治療CDMOサービス 市場規模：タイプ別 (2019-2024)
  • 中近東・アフリカ・中南米 細胞・遺伝子治療CDMOサービス 市場規模：タイプ別 (2025-2030)
  • 中近東・アフリカ・中南米 細胞・遺伝子治療CDMOサービスの市場シェア：タイプ別 (2019-2030)
• 中近東・アフリカ・中南米 細胞・遺伝子治療CDMOサービス 市場規模：用途別
  • 中近東・アフリカ・中南米 細胞・遺伝子治療CDMOサービス 市場規模：用途別 (2019-2024)
  • 中近東・アフリカ・中南米 細胞・遺伝子治療CDMOサービス 市場規模：用途別 (2025-2030)
  • 中近東・アフリカ・中南米 細胞・遺伝子治療CDMOサービスの市場シェア：用途別 (2019-2030)
• 中近東・アフリカ・中南米 細胞・遺伝子治療CDMOサービス 市場規模：国別
  • 中近東・アフリカ・中南米 細胞・遺伝子治療CDMOサービス 市場規模：国別: 2019 VS 2023 VS 2030
  • 中近東・アフリカ・中南米 細胞・遺伝子治療CDMOサービス 市場規模：国別 (2019-2024)
  • 中近東・アフリカ・中南米 細胞・遺伝子治療CDMOサービス 市場規模：国別 (2025-2030)
  • ブラジル
  • メキシコ
  • トルコ
  • サウジアラビア
  • イスラエル
  • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

• Catalent
• Lonza
• Thermo Fisher
• WuXi AppTec
• Charles River
• OxfordBioMedica
• BrammerBio
• CELLfor CURE
• OBiO Technology
• GenScript
• Esco
• Nikon
• FUJIFILM
• Pharmaron
• Porton
• Medicilon
• JOINN Laboratories
• Sofpromed
• eXmoor
• OmniaBio
• RoslinCT
• BioCentriq
• PolTREG
• Miltenyi Bioindustry

第12章 アナリストによる分析/結論

第13章 付録

List of Tables

Table 1. Global Cell and Gene Therapy CDMO Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Autologous Cell Therapy Products

Table 3. Key Players of Allogeneic Cell Therapy Products

Table 4. Global Cell and Gene Therapy CDMO Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Cell and Gene Therapy CDMO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Cell and Gene Therapy CDMO Services Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Cell and Gene Therapy CDMO Services Market Share by Region (2019-2024)

Table 8. Global Cell and Gene Therapy CDMO Services Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Cell and Gene Therapy CDMO Services Market Share by Region (2025-2030)

Table 10. Cell and Gene Therapy CDMO Services Market Trends

Table 11. Cell and Gene Therapy CDMO Services Market Drivers

Table 12. Cell and Gene Therapy CDMO Services Market Challenges

Table 13. Cell and Gene Therapy CDMO Services Market Restraints

Table 14. Global Cell and Gene Therapy CDMO Services Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Cell and Gene Therapy CDMO Services Market Share by Players (2019-2024)

Table 16. Global Top Cell and Gene Therapy CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CDMO Services as of 2023)

Table 17. Global Cell and Gene Therapy CDMO Services Industry Ranking 2022 VS 2023

Table 18. Global 5 Largest Players Market Share by Cell and Gene Therapy CDMO Services Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Cell and Gene Therapy CDMO Services, Headquarters and Area Served

Table 20. Global Key Players of Cell and Gene Therapy CDMO Services, Product and Application

Table 21. Global Key Players of Cell and Gene Therapy CDMO Services, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Cell and Gene Therapy CDMO Services Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Cell and Gene Therapy CDMO Services Revenue Market Share by Type (2019-2024)

Table 25. Global Cell and Gene Therapy CDMO Services Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Cell and Gene Therapy CDMO Services Revenue Market Share by Type (2025-2030)

Table 27. Global Cell and Gene Therapy CDMO Services Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Cell and Gene Therapy CDMO Services Revenue Market Share by Application (2019-2024)

Table 29. Global Cell and Gene Therapy CDMO Services Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Cell and Gene Therapy CDMO Services Revenue Market Share by Application (2025-2030)

Table 31. North America Cell and Gene Therapy CDMO Services Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Cell and Gene Therapy CDMO Services Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Cell and Gene Therapy CDMO Services Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Cell and Gene Therapy CDMO Services Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Cell and Gene Therapy CDMO Services Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Cell and Gene Therapy CDMO Services Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Cell and Gene Therapy CDMO Services Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Cell and Gene Therapy CDMO Services Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Cell and Gene Therapy CDMO Services Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Cell and Gene Therapy CDMO Services Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Cell and Gene Therapy CDMO Services Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Cell and Gene Therapy CDMO Services Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Cell and Gene Therapy CDMO Services Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Cell and Gene Therapy CDMO Services Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Cell and Gene Therapy CDMO Services Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Cell and Gene Therapy CDMO Services Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Cell and Gene Therapy CDMO Services Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Cell and Gene Therapy CDMO Services Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Cell and Gene Therapy CDMO Services Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Cell and Gene Therapy CDMO Services Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Cell and Gene Therapy CDMO Services Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030) & (US$ Million)

Table 63. Catalent Company Details

Table 64. Catalent Business Overview

Table 65. Catalent Cell and Gene Therapy CDMO Services Product

Table 66. Catalent Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 67. Catalent Recent Development

Table 68. Lonza Company Details

Table 69. Lonza Business Overview

Table 70. Lonza Cell and Gene Therapy CDMO Services Product

Table 71. Lonza Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 72. Lonza Recent Development

Table 73. Thermo Fisher Company Details

Table 74. Thermo Fisher Business Overview

Table 75. Thermo Fisher Cell and Gene Therapy CDMO Services Product

Table 76. Thermo Fisher Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 77. Thermo Fisher Recent Development

Table 78. WuXi AppTec Company Details

Table 79. WuXi AppTec Business Overview

Table 80. WuXi AppTec Cell and Gene Therapy CDMO Services Product

Table 81. WuXi AppTec Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 82. WuXi AppTec Recent Development

Table 83. Charles River Company Details

Table 84. Charles River Business Overview

Table 85. Charles River Cell and Gene Therapy CDMO Services Product

Table 86. Charles River Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 87. Charles River Recent Development

Table 88. OxfordBioMedica Company Details

Table 89. OxfordBioMedica Business Overview

Table 90. OxfordBioMedica Cell and Gene Therapy CDMO Services Product

Table 91. OxfordBioMedica Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 92. OxfordBioMedica Recent Development

Table 93. BrammerBio Company Details

Table 94. BrammerBio Business Overview

Table 95. BrammerBio Cell and Gene Therapy CDMO Services Product

Table 96. BrammerBio Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 97. BrammerBio Recent Development

Table 98. CELLfor CURE Company Details

Table 99. CELLfor CURE Business Overview

Table 100. CELLfor CURE Cell and Gene Therapy CDMO Services Product

Table 101. CELLfor CURE Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 102. CELLfor CURE Recent Development

Table 103. OBiO Technology Company Details

Table 104. OBiO Technology Business Overview

Table 105. OBiO Technology Cell and Gene Therapy CDMO Services Product

Table 106. OBiO Technology Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 107. OBiO Technology Recent Development

Table 108. GenScript Company Details

Table 109. GenScript Business Overview

Table 110. GenScript Cell and Gene Therapy CDMO Services Product

Table 111. GenScript Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 112. GenScript Recent Development

Table 113. Esco Company Details

Table 114. Esco Business Overview

Table 115. Esco Cell and Gene Therapy CDMO Services Product

Table 116. Esco Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 117. Esco Recent Development

Table 118. Nikon Company Details

Table 119. Nikon Business Overview

Table 120. Nikon Cell and Gene Therapy CDMO Services Product

Table 121. Nikon Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 122. Nikon Recent Development

Table 123. FUJIFILM Company Details

Table 124. FUJIFILM Business Overview

Table 125. FUJIFILM Cell and Gene Therapy CDMO Services Product

Table 126. FUJIFILM Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 127. FUJIFILM Recent Development

Table 128. Pharmaron Company Details

Table 129. Pharmaron Business Overview

Table 130. Pharmaron Cell and Gene Therapy CDMO Services Product

Table 131. Pharmaron Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 132. Pharmaron Recent Development

Table 133. Porton Company Details

Table 134. Porton Business Overview

Table 135. Porton Cell and Gene Therapy CDMO Services Product

Table 136. Porton Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 137. Porton Recent Development

Table 138. Medicilon Company Details

Table 139. Medicilon Business Overview

Table 140. Medicilon Cell and Gene Therapy CDMO Services Product

Table 141. Medicilon Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 142. Medicilon Recent Development

Table 143. JOINN Laboratories Company Details

Table 144. JOINN Laboratories Business Overview

Table 145. JOINN Laboratories Cell and Gene Therapy CDMO Services Product

Table 146. JOINN Laboratories Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 147. JOINN Laboratories Recent Development

Table 148. Sofpromed Company Details

Table 149. Sofpromed Business Overview

Table 150. Sofpromed Cell and Gene Therapy CDMO Services Product

Table 151. Sofpromed Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 152. Sofpromed Recent Development

Table 153. eXmoor Company Details

Table 154. eXmoor Business Overview

Table 155. eXmoor Cell and Gene Therapy CDMO Services Product

Table 156. eXmoor Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 157. eXmoor Recent Development

Table 158. OmniaBio Company Details

Table 159. OmniaBio Business Overview

Table 160. OmniaBio Cell and Gene Therapy CDMO Services Product

Table 161. OmniaBio Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 162. OmniaBio Recent Development

Table 163. RoslinCT Company Details

Table 164. RoslinCT Business Overview

Table 165. RoslinCT Cell and Gene Therapy CDMO Services Product

Table 166. RoslinCT Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 167. RoslinCT Recent Development

Table 168. BioCentriq Company Details

Table 169. BioCentriq Business Overview

Table 170. BioCentriq Cell and Gene Therapy CDMO Services Product

Table 171. BioCentriq Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 172. BioCentriq Recent Development

Table 173. PolTREG Company Details

Table 174. PolTREG Business Overview

Table 175. PolTREG Cell and Gene Therapy CDMO Services Product

Table 176. PolTREG Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 177. PolTREG Recent Development

Table 178. Miltenyi Bioindustry Company Details

Table 179. Miltenyi Bioindustry Business Overview

Table 180. Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Product

Table 181. Miltenyi Bioindustry Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024) & (US$ Million)

Table 182. Miltenyi Bioindustry Recent Development

Table 183. Research Programs/Design for This Report

Table 184. Key Data Information from Secondary Sources

Table 185. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cell and Gene Therapy CDMO Services Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Cell and Gene Therapy CDMO Services Market Share by Type: 2023 VS 2030

Figure 3. Autologous Cell Therapy Products Features

Figure 4. Allogeneic Cell Therapy Products Features

Figure 5. Global Cell and Gene Therapy CDMO Services Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Cell and Gene Therapy CDMO Services Market Share by Application: 2023 VS 2030

Figure 7. SMBs Case Studies

Figure 8. Large Companies Case Studies

Figure 9. Cell and Gene Therapy CDMO Services Report Years Considered

Figure 10. Global Cell and Gene Therapy CDMO Services Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global Cell and Gene Therapy CDMO Services Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Cell and Gene Therapy CDMO Services Market Share by Region: 2023 VS 2030

Figure 13. Global Cell and Gene Therapy CDMO Services Market Share by Players in 2023

Figure 14. Global Top Cell and Gene Therapy CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CDMO Services as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by Cell and Gene Therapy CDMO Services Revenue in 2023

Figure 16. North America Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America Cell and Gene Therapy CDMO Services Market Share by Type (2019-2030)

Figure 18. North America Cell and Gene Therapy CDMO Services Market Share by Application (2019-2030)

Figure 19. North America Cell and Gene Therapy CDMO Services Market Share by Country (2019-2030)

Figure 20. United States Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Cell and Gene Therapy CDMO Services Market Share by Type (2019-2030)

Figure 24. Europe Cell and Gene Therapy CDMO Services Market Share by Application (2019-2030)

Figure 25. Europe Cell and Gene Therapy CDMO Services Market Share by Country (2019-2030)

Figure 26. Germany Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. China Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Cell and Gene Therapy CDMO Services Market Share by Type (2019-2030)

Figure 34. China Cell and Gene Therapy CDMO Services Market Share by Application (2019-2030)

Figure 35. Asia Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia Cell and Gene Therapy CDMO Services Market Share by Type (2019-2030)

Figure 37. Asia Cell and Gene Therapy CDMO Services Market Share by Application (2019-2030)

Figure 38. Asia Cell and Gene Therapy CDMO Services Market Share by Region (2019-2030)

Figure 39. Japan Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. South Korea Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. China Taiwan Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Southeast Asia Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. India Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Australia Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Share by Type (2019-2030)

Figure 47. Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Share by Application (2019-2030)

Figure 48. Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Share by Country (2019-2030)

Figure 49. Brazil Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Mexico Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Turkey Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Israel Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. GCC Countries Cell and Gene Therapy CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Catalent Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 56. Lonza Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 57. Thermo Fisher Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 58. WuXi AppTec Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 59. Charles River Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 60. OxfordBioMedica Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 61. BrammerBio Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 62. CELLfor CURE Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 63. OBiO Technology Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 64. GenScript Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 65. Esco Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 66. Nikon Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 67. FUJIFILM Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 68. Pharmaron Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 69. Porton Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 70. Medicilon Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 71. JOINN Laboratories Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 72. Sofpromed Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 73. eXmoor Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 74. OmniaBio Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 75. RoslinCT Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 76. BioCentriq Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 77. PolTREG Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 78. Miltenyi Bioindustry Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2019-2024)

Figure 79. Bottom-up and Top-down Approaches for This Report

Figure 80. Data Triangulation

Figure 81. Key Executives Interviewed

This research report focuses on the Cell and Gene Therapy CDMO Services Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Cell and Gene Therapy CDMO Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
  • 1.2.2 Autologous Cell Therapy Products
  • 1.2.3 Allogeneic Cell Therapy Products
• 1.3 Market by Application
  • 1.3.1 Global Cell and Gene Therapy CDMO Services Market Share by Application: 2019 VS 2023 VS 2030
  • 1.3.2 SMBs
  • 1.3.3 Large Companies
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Cell and Gene Therapy CDMO Services Market Perspective (2019-2030)
• 2.2 Global Cell and Gene Therapy CDMO Services Growth Trends by Region
  • 2.2.1 Global Cell and Gene Therapy CDMO Services Market Size by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Cell and Gene Therapy CDMO Services Historic Market Size by Region (2019-2024)
  • 2.2.3 Cell and Gene Therapy CDMO Services Forecasted Market Size by Region (2025-2030)
• 2.3 Cell and Gene Therapy CDMO Services Market Dynamics
  • 2.3.1 Cell and Gene Therapy CDMO Services Industry Trends
  • 2.3.2 Cell and Gene Therapy CDMO Services Market Drivers
  • 2.3.3 Cell and Gene Therapy CDMO Services Market Challenges
  • 2.3.4 Cell and Gene Therapy CDMO Services Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Cell and Gene Therapy CDMO Services by Players
  • 3.1.1 Global Cell and Gene Therapy CDMO Services Revenue by Players (2019-2024)
  • 3.1.2 Global Cell and Gene Therapy CDMO Services Revenue Market Share by Players (2019-2024)
• 3.2 Global Cell and Gene Therapy CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Cell and Gene Therapy CDMO Services, Ranking by Revenue, 2022 VS 2023 VS 2024
• 3.4 Global Cell and Gene Therapy CDMO Services Market Concentration Ratio
  • 3.4.1 Global Cell and Gene Therapy CDMO Services Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy CDMO Services Revenue in 2023
• 3.5 Global Key Players of Cell and Gene Therapy CDMO Services Head office and Area Served
• 3.6 Global Key Players of Cell and Gene Therapy CDMO Services, Product and Application
• 3.7 Global Key Players of Cell and Gene Therapy CDMO Services, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Cell and Gene Therapy CDMO Services Breakdown Data by Type

• 4.1 Global Cell and Gene Therapy CDMO Services Historic Market Size by Type (2019-2024)
• 4.2 Global Cell and Gene Therapy CDMO Services Forecasted Market Size by Type (2025-2030)

5 Cell and Gene Therapy CDMO Services Breakdown Data by Application

• 5.1 Global Cell and Gene Therapy CDMO Services Historic Market Size by Application (2019-2024)
• 5.2 Global Cell and Gene Therapy CDMO Services Forecasted Market Size by Application (2025-2030)

6 North America

• 6.1 North America Cell and Gene Therapy CDMO Services Market Size (2019-2030)
• 6.2 North America Cell and Gene Therapy CDMO Services Market Size by Type
  • 6.2.1 North America Cell and Gene Therapy CDMO Services Market Size by Type (2019-2024)
  • 6.2.2 North America Cell and Gene Therapy CDMO Services Market Size by Type (2025-2030)
  • 6.2.3 North America Cell and Gene Therapy CDMO Services Market Share by Type (2019-2030)
• 6.3 North America Cell and Gene Therapy CDMO Services Market Size by Application
  • 6.3.1 North America Cell and Gene Therapy CDMO Services Market Size by Application (2019-2024)
  • 6.3.2 North America Cell and Gene Therapy CDMO Services Market Size by Application (2025-2030)
  • 6.3.3 North America Cell and Gene Therapy CDMO Services Market Share by Application (2019-2030)
• 6.4 North America Cell and Gene Therapy CDMO Services Market Size by Country
  • 6.4.1 North America Cell and Gene Therapy CDMO Services Market Size by Country: 2019 VS 2023 VS 2030
  • 6.4.2 North America Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024)
  • 6.4.3 North America Cell and Gene Therapy CDMO Services Market Share by Country (2025-2030)
  • 6.4.4 United States
  • 6.4.5 Canada

7 Europe

• 7.1 Europe Cell and Gene Therapy CDMO Services Market Size (2019-2030)
• 7.2 Europe Cell and Gene Therapy CDMO Services Market Size by Type
  • 7.2.1 Europe Cell and Gene Therapy CDMO Services Market Size by Type (2019-2024)
  • 7.2.2 Europe Cell and Gene Therapy CDMO Services Market Size by Type (2025-2030)
  • 7.2.3 Europe Cell and Gene Therapy CDMO Services Market Share by Type (2019-2030)
• 7.3 Europe Cell and Gene Therapy CDMO Services Market Size by Application
  • 7.3.1 Europe Cell and Gene Therapy CDMO Services Market Size by Application (2019-2024)
  • 7.3.2 Europe Cell and Gene Therapy CDMO Services Market Size by Application (2025-2030)
  • 7.3.3 Europe Cell and Gene Therapy CDMO Services Market Share by Application (2019-2030)
• 7.4 Europe Cell and Gene Therapy CDMO Services Market Size by Country
  • 7.4.1 Europe Cell and Gene Therapy CDMO Services Market Size by Country: 2019 VS 2023 VS 2030
  • 7.4.2 Europe Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024)
  • 7.4.3 Europe Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030)
  • 7.4.4 Germany
  • 7.4.5 France
  • 7.4.6 U.K.
  • 7.4.7 Italy
  • 7.4.8 Russia
  • 7.4.9 Nordic Countries

8 China

• 8.1 China Cell and Gene Therapy CDMO Services Market Size (2019-2030)
• 8.2 China Cell and Gene Therapy CDMO Services Market Size by Type
  • 8.2.1 China Cell and Gene Therapy CDMO Services Market Size by Type (2019-2024)
  • 8.2.2 China Cell and Gene Therapy CDMO Services Market Size by Type (2025-2030)
  • 8.2.3 China Cell and Gene Therapy CDMO Services Market Share by Type (2019-2030)
• 8.3 China Cell and Gene Therapy CDMO Services Market Size by Application
  • 8.3.1 China Cell and Gene Therapy CDMO Services Market Size by Application (2019-2024)
  • 8.3.2 China Cell and Gene Therapy CDMO Services Market Size by Application (2025-2030)
  • 8.3.3 China Cell and Gene Therapy CDMO Services Market Share by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Cell and Gene Therapy CDMO Services Market Size (2019-2030)
• 9.2 Asia Cell and Gene Therapy CDMO Services Market Size by Type
  • 9.2.1 Asia Cell and Gene Therapy CDMO Services Market Size by Type (2019-2024)
  • 9.2.2 Asia Cell and Gene Therapy CDMO Services Market Size by Type (2025-2030)
  • 9.2.3 Asia Cell and Gene Therapy CDMO Services Market Share by Type (2019-2030)
• 9.3 Asia Cell and Gene Therapy CDMO Services Market Size by Application
  • 9.3.1 Asia Cell and Gene Therapy CDMO Services Market Size by Application (2019-2024)
  • 9.3.2 Asia Cell and Gene Therapy CDMO Services Market Size by Application (2025-2030)
  • 9.3.3 Asia Cell and Gene Therapy CDMO Services Market Share by Application (2019-2030)
• 9.4 Asia Cell and Gene Therapy CDMO Services Market Size by Region
  • 9.4.1 Asia Cell and Gene Therapy CDMO Services Market Size by Region: 2019 VS 2023 VS 2030
  • 9.4.2 Asia Cell and Gene Therapy CDMO Services Market Size by Region (2019-2024)
  • 9.4.3 Asia Cell and Gene Therapy CDMO Services Market Size by Region (2025-2030)
  • 9.4.4 Japan
  • 9.4.5 South Korea
  • 9.4.6 China Taiwan
  • 9.4.7 Southeast Asia
  • 9.4.8 India
  • 9.4.9 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Size (2019-2030)
• 10.2 Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Size by Type (2019-2024)
  • 10.2.2 Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Size by Type (2025-2030)
  • 10.2.3 Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Share by Type (2019-2030)
• 10.3 Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Size by Application (2019-2024)
  • 10.3.2 Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Size by Application (2025-2030)
  • 10.3.3 Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Share by Application (2019-2030)
• 10.4 Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Size by Country: 2019 VS 2023 VS 2030
  • 10.4.2 Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Size by Country (2019-2024)
  • 10.4.3 Middle East, Africa, and Latin America Cell and Gene Therapy CDMO Services Market Size by Country (2025-2030)
  • 10.4.4 Brazil
  • 10.4.5 Mexico
  • 10.4.6 Turkey
  • 10.4.7 Saudi Arabia
  • 10.4.8 Israel
  • 10.4.9 GCC Countries

11 Key Players Profiles

• 11.1 Catalent
  • 11.1.1 Catalent Company Details
  • 11.1.2 Catalent Business Overview
  • 11.1.3 Catalent Cell and Gene Therapy CDMO Services Introduction
  • 11.1.4 Catalent Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.1.5 Catalent Recent Development
• 11.2 Lonza
  • 11.2.1 Lonza Company Details
  • 11.2.2 Lonza Business Overview
  • 11.2.3 Lonza Cell and Gene Therapy CDMO Services Introduction
  • 11.2.4 Lonza Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.2.5 Lonza Recent Development
• 11.3 Thermo Fisher
  • 11.3.1 Thermo Fisher Company Details
  • 11.3.2 Thermo Fisher Business Overview
  • 11.3.3 Thermo Fisher Cell and Gene Therapy CDMO Services Introduction
  • 11.3.4 Thermo Fisher Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.3.5 Thermo Fisher Recent Development
• 11.4 WuXi AppTec
  • 11.4.1 WuXi AppTec Company Details
  • 11.4.2 WuXi AppTec Business Overview
  • 11.4.3 WuXi AppTec Cell and Gene Therapy CDMO Services Introduction
  • 11.4.4 WuXi AppTec Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.4.5 WuXi AppTec Recent Development
• 11.5 Charles River
  • 11.5.1 Charles River Company Details
  • 11.5.2 Charles River Business Overview
  • 11.5.3 Charles River Cell and Gene Therapy CDMO Services Introduction
  • 11.5.4 Charles River Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.5.5 Charles River Recent Development
• 11.6 OxfordBioMedica
  • 11.6.1 OxfordBioMedica Company Details
  • 11.6.2 OxfordBioMedica Business Overview
  • 11.6.3 OxfordBioMedica Cell and Gene Therapy CDMO Services Introduction
  • 11.6.4 OxfordBioMedica Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.6.5 OxfordBioMedica Recent Development
• 11.7 BrammerBio
  • 11.7.1 BrammerBio Company Details
  • 11.7.2 BrammerBio Business Overview
  • 11.7.3 BrammerBio Cell and Gene Therapy CDMO Services Introduction
  • 11.7.4 BrammerBio Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.7.5 BrammerBio Recent Development
• 11.8 CELLfor CURE
  • 11.8.1 CELLfor CURE Company Details
  • 11.8.2 CELLfor CURE Business Overview
  • 11.8.3 CELLfor CURE Cell and Gene Therapy CDMO Services Introduction
  • 11.8.4 CELLfor CURE Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.8.5 CELLfor CURE Recent Development
• 11.9 OBiO Technology
  • 11.9.1 OBiO Technology Company Details
  • 11.9.2 OBiO Technology Business Overview
  • 11.9.3 OBiO Technology Cell and Gene Therapy CDMO Services Introduction
  • 11.9.4 OBiO Technology Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.9.5 OBiO Technology Recent Development
• 11.10 GenScript
  • 11.10.1 GenScript Company Details
  • 11.10.2 GenScript Business Overview
  • 11.10.3 GenScript Cell and Gene Therapy CDMO Services Introduction
  • 11.10.4 GenScript Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.10.5 GenScript Recent Development
• 11.11 Esco
  • 11.11.1 Esco Company Details
  • 11.11.2 Esco Business Overview
  • 11.11.3 Esco Cell and Gene Therapy CDMO Services Introduction
  • 11.11.4 Esco Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.11.5 Esco Recent Development
• 11.12 Nikon
  • 11.12.1 Nikon Company Details
  • 11.12.2 Nikon Business Overview
  • 11.12.3 Nikon Cell and Gene Therapy CDMO Services Introduction
  • 11.12.4 Nikon Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.12.5 Nikon Recent Development
• 11.13 FUJIFILM
  • 11.13.1 FUJIFILM Company Details
  • 11.13.2 FUJIFILM Business Overview
  • 11.13.3 FUJIFILM Cell and Gene Therapy CDMO Services Introduction
  • 11.13.4 FUJIFILM Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.13.5 FUJIFILM Recent Development
• 11.14 Pharmaron
  • 11.14.1 Pharmaron Company Details
  • 11.14.2 Pharmaron Business Overview
  • 11.14.3 Pharmaron Cell and Gene Therapy CDMO Services Introduction
  • 11.14.4 Pharmaron Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.14.5 Pharmaron Recent Development
• 11.15 Porton
  • 11.15.1 Porton Company Details
  • 11.15.2 Porton Business Overview
  • 11.15.3 Porton Cell and Gene Therapy CDMO Services Introduction
  • 11.15.4 Porton Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.15.5 Porton Recent Development
• 11.16 Medicilon
  • 11.16.1 Medicilon Company Details
  • 11.16.2 Medicilon Business Overview
  • 11.16.3 Medicilon Cell and Gene Therapy CDMO Services Introduction
  • 11.16.4 Medicilon Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.16.5 Medicilon Recent Development
• 11.17 JOINN Laboratories
  • 11.17.1 JOINN Laboratories Company Details
  • 11.17.2 JOINN Laboratories Business Overview
  • 11.17.3 JOINN Laboratories Cell and Gene Therapy CDMO Services Introduction
  • 11.17.4 JOINN Laboratories Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.17.5 JOINN Laboratories Recent Development
• 11.18 Sofpromed
  • 11.18.1 Sofpromed Company Details
  • 11.18.2 Sofpromed Business Overview
  • 11.18.3 Sofpromed Cell and Gene Therapy CDMO Services Introduction
  • 11.18.4 Sofpromed Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.18.5 Sofpromed Recent Development
• 11.19 eXmoor
  • 11.19.1 eXmoor Company Details
  • 11.19.2 eXmoor Business Overview
  • 11.19.3 eXmoor Cell and Gene Therapy CDMO Services Introduction
  • 11.19.4 eXmoor Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.19.5 eXmoor Recent Development
• 11.20 OmniaBio
  • 11.20.1 OmniaBio Company Details
  • 11.20.2 OmniaBio Business Overview
  • 11.20.3 OmniaBio Cell and Gene Therapy CDMO Services Introduction
  • 11.20.4 OmniaBio Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.20.5 OmniaBio Recent Development
• 11.21 RoslinCT
  • 11.21.1 RoslinCT Company Details
  • 11.21.2 RoslinCT Business Overview
  • 11.21.3 RoslinCT Cell and Gene Therapy CDMO Services Introduction
  • 11.21.4 RoslinCT Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.21.5 RoslinCT Recent Development
• 11.22 BioCentriq
  • 11.22.1 BioCentriq Company Details
  • 11.22.2 BioCentriq Business Overview
  • 11.22.3 BioCentriq Cell and Gene Therapy CDMO Services Introduction
  • 11.22.4 BioCentriq Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.22.5 BioCentriq Recent Development
• 11.23 PolTREG
  • 11.23.1 PolTREG Company Details
  • 11.23.2 PolTREG Business Overview
  • 11.23.3 PolTREG Cell and Gene Therapy CDMO Services Introduction
  • 11.23.4 PolTREG Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.23.5 PolTREG Recent Development
• 11.24 Miltenyi Bioindustry
  • 11.24.1 Miltenyi Bioindustry Company Details
  • 11.24.2 Miltenyi Bioindustry Business Overview
  • 11.24.3 Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Introduction
  • 11.24.4 Miltenyi Bioindustry Revenue in Cell and Gene Therapy CDMO Services Business (2019-2024)
  • 11.24.5 Miltenyi Bioindustry Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer